Inhibitory Effect of Chimera Decoy Oligodeoxynucleotides (ODN) against Ets and NFκ B on the Progression of Rabbit Experimental Aortic Aneurysms (AAA)

スポンサーリンク

概要

• 論文の詳細を見る
• 社団法人日本循環器学会の論文
• 2003-03-01

著者

• OGIHARA Toshio

  Osaka University

• KANEDA Yasufumi

  Division of Gene Therapy Science, Graduate School of Medicine, Osaka University

• Aoki Motokuni

  Department Of Clinical Gene Therapy Osaka University Graduate School Of Medicine

• Aoki Motokuni

  Department Of Geriatric Medicine

• Aoki Motokuni

  Department Of Geriatric Medicine Osaka University Medical School

• Morishita Ryuichi

  Division Of Gene Therapy Science Osaka University Graduate School Of Medicine

• Kaneda Yasufumi

  Division Of Clinical Gene Therapy Osaka University Graduate School Of Medicine

• Nakashima Hideki

  Division Of Gene Therapy Science Osaka University Graduate School Of Medicine

• Miyake Takashi

  Division of Gene Therapy Science, Osaka University Graduate School of Medicine

• Aoki Motokuni

  Osaka, Japan

• Ogihara Toshio

  Osaka General Medical Center

• Morishita Ryuichi

  Division Of Clinical Gene Therapy

• Nakashima Hideki

  Division Of Clinical Gene Therapy Osaka University Graduate School Of Medicine

• Miyake Takashi

  Division Of Clinical Gene Therapy Osaka University Graduate School Of Medicine

• Morishita Ryuichi

  Department Cf Clinical Gene Therapy Graduate School Of Medicine Osaka University

• Miyake Takashi

  Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University

関連論文

• The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
• Accumulation of common polymorphisms is associated with development of hypertension : a 12-year follow-up from the Ohasama study
• A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension : the REZALT study
• Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats
• Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease : subanalysis of the CASE-J Study
• Effects of Cardiac Complications on Cardiovascular Events in Japanese High-Risk Hypertensive Patients : Subanalysis of the CASE-J Trial
• Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction
• Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications : a sub-analysis of the CASE-J trial
• Efficient Transfer of Intact Oligonucleotides into the Nucleus of Ligament Scar Fibroblasts by HVJ-Cationic Liposomes Is Correlated with Effective Antisense Gene Inhibition^1
• OE-071 A Genom-Wide Association Study of SNPs in the risk of Atherosclerosis Obliterans(Heart failure, clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial
• 1 Which Risk Factor Has an Adverse Effect on Coronary Events in Japanese High-risk Hypertensive Patients? : a Subanalysis of CASE-J(Comprehensive Risk Management for Prevention of Coronary Artery Disease,Symposium 16 (SY-16) (H),The 73rd Annual Scientific
• 4 On-going Japanese Clinical Trials for Hypertension II : Seeking for More Effective Pharmacological Treatment(ESC-JCS Joint Symposium (ESC-JCS Joint Symposium) (H) Evidence-Based Medical Treatment of Hypertension,Special Program,The 72nd Annual Scientifi
• 1 Which Risk Factor Has an Adverse Effect on Coronary Events in Japanese High-risk Hypertensive Patients? : a Subanalysis of CASE-J(Comprehensive Risk Management for Prevention of Coronary Artery Disease,Symposium 16 (SY-16) (H),The 73rd Annual Scientific
• Variation in OSBPL10 is associated with dyslipidemia
• 3 Clinical Outcomes in Hypertensive Patients with High Cardiovascular Risks : Principal Results of Candesartan Antihyopertensive Survival Evaluation in Japan (CASE-J) Study(Late Breaking Clinical Trials in Japan, The 71st Annual Scientific Meeting of the
• The Optimal Target Blood Pressure for Antihypertensive Treatment in Japanese Elderly Patients with High-Risk Hypertension : A Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
• PJ-042 Pivotal Roles of CYLD (cylindromatosis) as a Deubiquitinating Enzyme in Vasculature(Atherosclerosis, basic(05)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Lack of Association between the Hepatocyte Growth Factor Receptor, c-met, and the Anti-Apoptotic Action of Bag-1 in Endothelial Cells
• Rationale for Time-Qualified Reference Standards for 24-Hour Blood Pressure Values and Their Circadian Rhythms in Japanese Normotensive Adults : A Study by the Ambulatory Blood Pressure Monitoring Research Group
• The Importance of Home Blood Pressure Measurement for Preventing Stroke and Cardiovascular Disease in Hypertensive Patients : A Sub-Analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a Prospecti
• Impact of Blood Pressure Control on Cardiovascular Events in 26,512 Japanese Hypertensive Patients : The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a Prospective Nationwide Observational Study
• Efficacy and Safety of Long-Term Losartan Therapy Demonstrated by a Prospective Observational Study in Japanese Patients with Hypertension : The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study
• Design and Baseline Characteristics of an Observational Study in Japanese Patients with Hypertension : Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH)
• Recovery of Learning and Memory by Gene Therapy Using Hepatocyte Growth Factor Gene After Focal Cerebral Ishcemia in Rats(Gene Therapy/Genetic Engineering (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Gene Polymorphism of Myospryn (Cardiomyopathy-Associated 5) Is Associated with Left Ventricular Wall Thickness in Patients with Hypertension
• Inhibitory Effect of Chimera Decoy Oligodeoxynucleotides (ODN) against Ets and NFκ B on the Progression of Rabbit Experimental Aortic Aneurysms (AAA)
• Gene Therapy for Abdominal Aortic Aneurysm (AAA) using Decoy Strategy against ets binding site
• Effect of E2F decoy on inhibitation of neointima formation in pig coronary arteries after balloon injury and stent implantation
• Transcription factor, ets-1, is a novel angiogenic molecule : Implication to ciene therapy to treat peripheral arterial disease
• Novel molecular intervention to treat abdominal aortic aneurysms (AAA) using chimera decoy oligodeoxynucleotides (ODN) against ets and NFkB binding sites
• Therapeutic Angiogenesis Induced by Endotherial Nitric Oxide Synthase Gene through VEGF Expression in Rat Hindlimb Ischemia Model
• The Aldehyde Dehydrogenase 2 Gene Is a Risk Factor for Hypertension in Japanese but Does Not Alter the Sensitivity to Pressor Effects of Alcohol : The Suita Study
• Polymorphism of myospryn is associated with left ventricular diastolic dysfunction
• Increase in DNA Synthesis of Cardiac Myocytes by Transfection ofP53 and Rb Antisense : Possibility of Cardiac Myocytes Regeneration
• GENETIC ASSOCIATION OF SUMO4 GENE, AS A CANDIDATE GENE FOR IDDM5, WITH SUSCEPTIBILITY TO TYPE 1 DIABETES IN ASIAN POPULATIONS
• Azelnidipine and Amlodipine: a Comparrison of Their Pharmacokinetics and Effects on Ambulatory Blood Pressure
• Hypertension and Risk Stratification
• Rationale, study design and implementation of the COLM study : the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients
• Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve
• PE-062 Zyxin Progresses Epithelial-Mesenchymal Transition under the Control of Twist1 and Contributes to Endocardial Morphogenesis(PE011,Congenital Heart Disease (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation S
• PJ-086 Regression of Experimental Rabbit Aortic Aneurysm by The Treatment with Chimera Decoy Oligodeoxynucleotides (ODN) against ets and NFkB(Gene Therapy 1 (IHD) : PJ15)(Poster Session (Japanese))
• PJ-652 Over-expression of HGF Improves Learning and Memory and Prevents Progressive Shrinkage of Thalamus in the Chronic Stage of Cerebral Infarction(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70th Anniversary Annual Scie
• -490- CONTRIBUTION OF AREA POSTREMA AND ANTEROVENTRAL THIRD VENTRICLE TO PRESSOR ACTIONS OF ANGIOTENSIN II IN DOGS
• 3 Functional Analysis of Novel Antimicrobial Peptide, AG (Angiogenic Peptide)-30, with Angiongenic Property, toward Clinical Application(The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• IS033 UP-REGULATION OF KEY TRANSCRIPTIONAL FACTOR FOR ANGIOGENESIS, ETS, AND INDUCTION OF ANGIOGENESIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) INTO MYOCARDIUM
• Contribution of a Vascular Modulator, Hepatocyte Growth factor (HGF), to the Pathogenesis of Cardiovascular Disease
• IS053 ANTI-APOPTOTIC ACTION OF HEPATOCYTE GROWTH FACTOR ON HUMAN AORTIC ENDOTHELIAL CELLS
• Potential Role of a Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), in Cardiovascular Disease: Characterization and Regulation of Local HGF System
• PE-275 A Novel Strategy of the Gene Therapy for PAD Using Small RNA Interference of Cold Shock Domain Protein A(PE046,Atherosclerosis (Basic, Clinical/Diagnosis) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation
• PJ-250 Cold shock domain protein A, novel regulator of angiogenesis in heart.(Coronary circulation, basic/clinical(03)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• OE-185 Topical application of novel angiogenic peptide, AG-30, in wound healing model(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• OE-040 FHL-2 Expresses in Endothelial Cell and Suppresses VEGF-induced Angiogenesis Via Sphingosine Kinase-1(Arrhythmia, diagnosis/Pathophysiology/EPS(01)(A),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society
• OJ-195 Pivotal Roles of Deubiquitinating Enzymes UCHL1, HAUSP, and CYLD in Vasculature as an Anti-proliferative and Anti-inflammatory Effect(Atherosclerosis, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Adipose Tissue-Derived Stromal Cells as a Novel Option for Regenerative Cell Therapy
• PJ-477 A Therapeutic Strategy to Treat Brain Ischemia : Over-expression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury in Rat Model(Cerebrovascular Circulation/Stroke 1 (H) : PJ80)(Poster Session (Japanese))
• Guidelines for Treatment of Hypertension in the Elderly : 2002 Revised Version
• PJ-098 Ubiquitin C-terminal Hydroxylase L1 (UCHL1), the Causative Genes of Inherited Parkinson's Disease, Has an Anti-inflammatory Action in Endothelial Cells(Molecular biology, vascular-3 (H) PJ17,Poster Session (Japanese),The 70th Anniversary Annual Sci
• PE-114 Angiotensin II Blocker, Valsartan, Supresses the Development of Experimental Abdominal Aortic Aneurysm in Rats(Peripheral circulation/Vascular disease(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
• PJ-691 Inhibition of Development of Experimental Aortic Abdominal Aneurysm in Rat Model by Atorvastatin through Inhibition of Macrophage Migration(Peripheral circulation/Vascular disease-6, The 71st Annual Scientific Meeting of the Japanese Circulation So
• PE-543 Inhibiton of Experimental Aortic Abdominal Aneurysm by Angiotensin Receptor Blocker, Valsartan(Peripheral circulation/Vascular disease-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Two Years Follow-up of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Peripheral Circulation/Vascular Disease (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Clinical Trial of Human Gene Therapy Using Hepatocyte Growth Factor Gene Transfer(Translational Research in Cardiovascular Disease, The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• FRS-013 Long Term Evaluation of Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Angiogenesis and Regeneration Medicine in Cardiovascular Medicine (M) : FRS3)(Featured Research Session (Engl
• Increase in Peripheral Blood Flow by Intravenous Administration of Prostaglandin E1 in Patients with Peripheral Arterial Disease, Accompanied by Up-Regulation of Hepatocyte Growth Factor
• Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin 12 Analogue) in the Porcine Coronary Artery after Angioplasty
• Results of Safety from Human Clinical Gene Therapy Using HGF (TREAT-HGF)
• Long Term Evaluation of Results from the First Stage in the Clinical Trial of Gene Therapy for Peripheral Arterial Disease
• Clinical Results of TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer)
• Evaluation of utility of prostagrandin E1 in the patients with ASO : Protective effect on endothelial function through up-regulation of HGF
• No increase in human HGF concentration in the patients transfected with human HGF plasmid : preliminary clinical results from TREAT-HGF
• Preliminary clinical results from TREAT-HGF (Japan Trial to Treat Peripheral Arterial Disease by Therapeutic Angiogenesis Using HGF Gene Transfer)
• Preliminary clinical results from TREAT-HGF : Gene therapy for PAD
• OJ-213 Prevention of Abdominal Aortic Aneurysm using Ribbon-type Chimeric Decoy Oligodeoxynucleotides against NF κ B and Ets in a Rat Model(Genetics/Genetically engineered models/Gene therapy-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circ
• OJ-028 Role of NF κ B and Ets in Development of Abdominal Aortic Aneurysm in Human(Peripheral circulation/Vascular disease-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• 5 Clinical Trial of Human Gene Therapy for Peripheral Arterial Disease Using Hepatocyte Growth Factor Gene Transfer(Clinical Trials of Regeneration Therapy in Japan, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-391 Hypertension Accelerated Experimental Abdominal Aortic Aneurysm through Up-regulation of Transcription Factors, NFkB and Ets(Peripheral circulation-2 (H) OJ66,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japane
• OE-328 Increase in DNA Synthesis of Cardiomyocytes by Transfection of Antisense p53 and Rb Oligodeoxynucleotides : Possibility of Regeneration of Cardiomyocytes(Gene Therapy 2 (IHD) : OE41)(Oral Presentation (English))
• OE-141 Cardio-cerebral and Cardio-renal Complications in High-risk Hypertensive Patients with Cardiac Risks Based on the Results of CASE-J Trial(Hypertension, clinical(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Ci
• FRS-003 Prognostic Value of Left Ventricular Hypertrophy and Changes in Left Ventricular Mass in Hypertensive Patients : An analysis of CASE-J Trial(New Clinical Aspects for Hypertension(H),Featured Research Session,The 72nd Annual Scientific Meeting of t
• 1 To Make the Best Use of Japanese Evidences to Future Guidelines : From the Results and Experiences of CASE-J Trial(Symposium 18 (SY-18) (H) How can we Make the Best Use of Japanese Evidences for Future Guidelines,Special Program,The 72nd Annual Scientif
• Therapeutic Angiogenesis Induced by Transfection of Hepatocyte Growth Factor (HGF) Gene in Porcine Myocardial Infarction Model
• Acceleration of Neointimal Hyperplasia in Lp (a) Transgenic Mice : Contribution of Lp (a) in the Pathogenesis of Vascular Disease
• Novel High Efficiency Gene transfer Technique into neonatal cardiac myocyte : Second Generation of HVJ vector (HVJ-envelope)
• Impairment of collateral formation in Lp(a) transgenic mice : Therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene
• Acceleration of neointimal hyperplasia in Lp(a) transgenic mice : Contribution of Lp(a) in the pathogenesis of vascular disease
• Synaptotagmin I hypothalamic knockdown prevents amygdaloid seizure-induced damage of hippocampal neurons but not of entorhinal neurons
• Antisense in vivo knockdown of synaptotagmin I and synapsin I by HVJ-liposome mediated gene transfer modulates ischemic injury of hippocampus in opposing ways
• Microbubble-enhanced ultrasound for gene transfer into living skin equivalents
• PE-383 HGF Gene Therapy Ameliorates Secondary Lymphedema through Lymphangiogenesis(Genetics/Genetically engineered models/Gene therapy-2 (M) PE64,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• Non-viral vectors for cancer therapy
• Development of non-viral gene delivery system
• Vascular Specific Organogenesis from Embryonic Stem Cells on Three Dimensional Layer of Matrigel
• Development of Novel High Throughput Functional Screening System Based on HVJ-E Vector : Screening of Anti-vascular Remodeling Factor in Hypertension(Hypertension, Basic 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Gene Therapy to Treat Diabetic Neuropathy : Improvement of Diabetic Peripheral Neuropathy by HGF Gene and Prostacyclin Synthase Gene Transfer
• Co-Transfection of Human Hepatocyte Growth Factor and Prostacyclin Synthase Gene Enhanced Therapeutic Angiogenesis in Rat and Rabbit Ischemia Model
• Development of Novel Therapeutic Angiogenesis Strategy Using Co-transfection of Human PGIS Gene with HGF as Preclinical Study
• A Novel Autologous Cell Therapy into Ischemic Limb Diseases by Adipose Tissue-derived Stromal Cells through Growth Factor Secretion(Vasoactive Compound/Growth Factor/Cytokine 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Therapeutic Angiogenesis Induced by Hepatocyte Growth Factor : Potential Gene Therapy for Ischemic diseases
• IS026 Hypoxia Induced Endothelial Apoptosis Through the Activation of NFkB : In Vivo Evidence of Importance of NFkb in Endothelial Cell Regulation

もっと見る 閉じる

スポンサーリンク